Michael Thompson: Covid-19 lessons to optimise cancer clinical trial operations
Are there different investigator skillsets involved in running the varied stages of oncology trials?
Diagnostics
Delayed diagnosis increases the burden of bipolar disorder
New research suggests long delays to bipolar disorder diagnosis, which may increase the burden the...
In conversation: nonalcoholic steatohepatitis investigator Rohit Loomba
Top NASH investigator Rohit Loomba discusses the potential of imaging in replacing biopsies, and much...
AI in healthcare: key highlights in 2021
As AI and machine learning continues to evolve, we look at how it has impacted...
New blood test could improve prostate cancer screening
A new novel blood test called the Stockholm3test could boost the prostate cancer screening process...
Promising therapeutics on horizon for recurrent and metastatic cervical cancer
Alternative treatment options for recurrent and metastatic cervical cancer can transform the landscape and satisfy unmet needs.
First successful trial in heart failure with preserved ejection fraction
According to the trial results, Jardiance reduces the risk of death or hospitalisation due to heart failure for diabetic and non-diabetic patients with HFpEF.
Service planning in Europe would benefit from complete registration of NMSCs
All cases of BCC, a type of NMSC, should be reported for better treatment planning and preventative health promotion campaigns.
Low rates of migraine diagnosis further hindered by COVID-19 pandemic
Despite having a significant impact on quality of life, less than half of people with migraine are diagnosed.
Impact of underdiagnosis of plaque psoriasis in Black and Hispanic Americans
Underdiagnosed plaque psoriasis in Black and Hispanic Americans can severely impact their quality of life and more training can help clinical decisions.
ACC 21: Mavacamten improves health status in symptomatic HCM
Results from the Phase III trial EXPLORE-HCM presented at the 70th annual American College of Cardiology (ACC) 2021 showed that mavacamten positively benefits the health status of patients with symptomatic oHCM.
